Page 2 - Hikal

Here's why Mehul Kothari recommends buying Hikal, Jindal Saw

According to the technical analyst from Anand Rathi, JINDALSAW has seen a strong resurgence in the last two sessions backed by robust volumes indicating soaring demand at lower levels

Here's why Subash Gangadharan is bullish on Hikal, Gujarat Gas

The technical & derivative analyst from HDFC Securities expects weakness in Nifty to continue

Hikal hits new high on signing 10-year deal with global pharma Co

This contract entails the development and supply of a portfolio of niche APIs (Active Pharmaceutical Ingredient) over a period of 10 years

Hikal's profit after tax rises 42.8% to Rs 40 crore in December quarter

Hikal on Thursday reported a 42.85 per cent rise to Rs 40 crore in consolidated profit after tax (PAT) during the quarter ended December 31, 2020.

Hikal shares advance 12%, hit 52-week high on growth prospects

For the April-June quarter (Q1FY21), Hikal reported a 25 per cent year-on-year (YoY) decline in its consolidated profit before tax (PBT) at Rs 27.50 crore.

Hikal freezes at 5% upper circuit on development of Favipiravir API

Favipiravir is in various stages of clinical trials in many countries as an experimental treatment of Covid-19.

Hikal hits 52-week high after Ashish Kacholia buys 1.6% stake

Hikal hits 52-week high of Rs 192, up 4% on Tuesday, extending its previous day's 15% surge on the National Stock Exchange.

Hikal soars as USFDA issues 'Zero' 483 observations for Bangalore facility

The stock soared 18% to Rs 257, also its record high on the NSE in intra-day trade